论文部分内容阅读
卵巢癌的基因治疗业已取得了很大的进展。重组回旋病毒、腺病毒或非病毒脂质体有可能作为安全、有效的媒介物质 ;分子化学疗法、突变补偿、免疫增强和耐药性变化等基因治疗方法不断得到了发展和完善。部分治疗方案 (特别是单纯疱疹病毒胸腺嘧啶脱氧核苷激酶方案等 )已进入了临床试用阶段
Ovarian cancer gene therapy has made great progress. Recombinant malaria, adenovirus or non-viral liposomes may be safe and effective vector substance; molecular chemotherapy, mutation compensation, immune enhancement and drug resistance changes and other gene therapy has been developed and improved. Some of the treatment programs (especially the herpes simplex virus thymidine kinase program, etc.) have entered the clinical trial phase